Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:05:48.618Z.
Calculation as of: 2026-10-06T19:05:48.618Z.
Quote observation: 2026-10-06T19:05:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c3badec668e3f46c99710567a4b8f8b80f25eadce34b54ca393ff31220dc4819
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-02-28.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
6.76x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Atea Pharmaceuticals, Inc.
Market Cap
$401.34M
EV/EBITDA Ratio
N/A
TTM Avg
6.76x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$403.77M
EV/EBITDA Ratio
N/A
TTM Avg
30.26x
3Y Avg
22.88x
5Y Avg
18.64x
Market Cap
$413.16M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$414.45M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $401.34M | N/A | 6.76x | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $403.77M | N/A | 30.26x | 22.88x | 18.64x |
| Shoulder Innovations, Inc. (SI)vs › | $402.11M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $406.55M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $409.04M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $408.28M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $413.16M | N/A | N/A | N/A | N/A |
| REGENXBIO Inc. (RGNX)vs › | $394.09M | N/A | 7.49x | 7.49x | 18.24x |
| MapLight Therapeutics, Inc. (MPLT)vs › | $414.45M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $415.78M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2023-02-28 | 3.98x |
| 2023-02-27 | 4.03x |
| 2023-02-24 | 4.33x |
| 2023-02-23 | 4.87x |
| 2023-02-22 | 5.20x |
| 2023-02-21 | 5.28x |
| 2023-02-17 | 5.91x |
| 2023-02-16 | 5.53x |
| 2023-02-15 | 5.47x |
| 2023-02-14 | 5.42x |
| 2023-02-13 | 5.80x |
| 2023-02-10 | 5.80x |
| 2023-02-09 | 5.72x |
| 2023-02-08 | 6.26x |
| 2023-02-07 | 6.67x |
| 2023-02-06 | 6.72x |
| 2023-02-03 | 6.62x |
| 2023-02-02 | 7.24x |
| 2023-02-01 | 6.91x |
| 2023-01-31 | 6.94x |
| 2023-01-30 | 6.89x |
| 2023-01-27 | 6.86x |
| 2023-01-26 | 6.78x |
| 2023-01-25 | 6.59x |
| 2023-01-24 | 6.72x |
| 2023-01-23 | 7.27x |
| 2023-01-20 | 7.68x |
| 2023-01-19 | 7.49x |
| 2023-01-18 | 7.16x |
| 2023-01-17 | 7.73x |
| 2023-01-13 | 7.76x |
| 2023-01-12 | 7.68x |
| 2023-01-11 | 7.40x |
| 2023-01-10 | 7.87x |
| 2023-01-09 | 7.08x |
| 2023-01-06 | 7.13x |
| 2023-01-05 | 7.11x |
| 2023-01-04 | 7.35x |
| 2023-01-03 | 7.43x |
| 2022-12-30 | 7.43x |
| 2022-12-29 | 7.05x |
| 2022-12-28 | 6.18x |
| 2022-12-27 | 6.23x |
| 2022-12-23 | 6.83x |
| 2022-12-22 | 6.89x |
| 2022-12-21 | 6.81x |
| 2022-12-20 | 6.67x |
| 2022-12-19 | 6.26x |
| 2022-12-16 | 6.89x |
| 2022-12-15 | 6.29x |
| 2022-12-14 | 6.34x |
| 2022-12-13 | 6.56x |
| 2022-12-12 | 6.29x |
| 2022-12-09 | 6.29x |
| 2022-12-08 | 6.89x |
| 2022-12-07 | 6.83x |
| 2022-12-06 | 7.02x |
| 2022-12-05 | 7.05x |
| 2022-12-02 | 7.40x |
| 2022-12-01 | 7.35x |
| 2022-11-30 | 7.11x |
| 2022-11-29 | 6.81x |
| 2022-11-28 | 6.78x |
| 2022-11-25 | 7.11x |
| 2022-11-23 | 7.11x |
| 2022-11-22 | 7.16x |
| 2022-11-21 | 6.64x |
| 2022-11-18 | 7.05x |
| 2022-11-17 | 7.02x |
| 2022-11-16 | 7.49x |
| 2022-11-15 | 8.44x |
| 2022-11-14 | 8.22x |
| 2022-11-11 | 8.41x |
| 2022-11-10 | 8.22x |
| 2022-11-09 | 7.24x |
| 2022-11-08 | 8.74x |
| 2022-08-24 | 0.00x |
| 2022-08-19 | 0.21x |
| 2022-08-18 | 0.68x |
| 2022-08-17 | 1.29x |
| 2022-08-16 | 1.56x |
| 2022-08-15 | 1.35x |
| 2022-08-12 | 0.78x |
| 2022-08-11 | 0.17x |
| 2022-08-10 | 0.31x |
| 2022-08-09 | 1.02x |
| 2022-08-08 | 0.18x |
| 2022-08-05 | 0.43x |
| 2022-08-04 | 0.00x |
| 2022-08-03 | 0.03x |
| 2022-07-13 | 0.05x |
| 2021-11-16 | 2.68x |
| 2021-11-15 | 2.98x |
| 2021-11-12 | 4.36x |
| 2021-11-11 | 2.86x |
| 2021-11-10 | 2.92x |
| 2021-11-09 | 3.44x |
| 2021-11-08 | 3.09x |
| 2021-11-05 | 3.21x |
| 2021-11-04 | 5.23x |
| 2021-11-03 | 5.67x |
| 2021-11-02 | 5.10x |
| 2021-11-01 | 5.69x |
| 2021-10-29 | 4.94x |
| 2021-10-28 | 5.60x |
| 2021-10-27 | 6.04x |
| 2021-10-26 | 6.50x |
| 2021-10-25 | 7.18x |
| 2021-10-22 | 7.20x |
| 2021-10-21 | 7.24x |
| 2021-10-20 | 8.26x |
| 2021-10-19 | 9.47x |
| 2021-10-18 | 65.13x |
| 2021-10-15 | 62.38x |
| 2021-10-14 | 64.81x |
| 2021-10-13 | 67.41x |
| 2021-10-12 | 60.53x |
| 2021-10-11 | 61.47x |
| 2021-10-08 | 64.00x |
| 2021-10-07 | 66.02x |
| 2021-10-06 | 63.61x |
| 2021-10-05 | 68.78x |
| 2021-10-04 | 73.42x |
| 2021-10-01 | 68.06x |
| 2021-09-30 | 53.61x |
| 2021-09-29 | 47.52x |
| 2021-09-28 | 47.54x |
| 2021-09-27 | 50.91x |
| 2021-09-24 | 47.54x |
| 2021-09-23 | 47.19x |
| 2021-09-22 | 46.36x |
| 2021-09-21 | 39.87x |
| 2021-09-20 | 40.89x |
| 2021-09-17 | 35.26x |
| 2021-09-16 | 37.13x |
| 2021-09-15 | 34.74x |
| 2021-09-14 | 38.36x |
| 2021-09-13 | 38.69x |
| 2021-09-10 | 40.19x |
| 2021-09-09 | 40.31x |
| 2021-09-08 | 38.32x |
| 2021-09-07 | 42.41x |
| 2021-09-03 | 40.83x |
| 2021-09-02 | 41.02x |
| 2021-09-01 | 40.25x |
| 2021-08-31 | 42.51x |
| 2021-08-30 | 44.13x |
| 2021-08-27 | 45.90x |
| 2021-08-26 | 41.50x |
| 2021-08-25 | 44.24x |
| 2021-08-24 | 42.66x |
| 2021-08-23 | 42.62x |
| 2021-08-20 | 42.39x |
| 2021-08-19 | 42.01x |
| 2021-08-18 | 41.45x |
| 2021-08-17 | 40.48x |
| 2021-08-16 | 38.69x |
| 2021-08-13 | 38.25x |
| 2021-08-12 | 81.82x |
| 2021-08-11 | 88.97x |
| 2021-08-10 | 88.59x |
| 2021-08-09 | 86.19x |
| 2021-08-06 | 82.01x |
| 2021-08-05 | 69.75x |
| 2021-08-04 | 64.82x |
| 2021-08-03 | 69.53x |
| 2021-08-02 | 62.91x |
| 2021-07-30 | 59.00x |
| 2021-07-29 | 56.40x |
| 2021-07-28 | 58.96x |
| 2021-07-27 | 62.79x |
| 2021-07-26 | 56.96x |
| 2021-07-23 | 59.26x |
| 2021-07-22 | 60.84x |
| 2021-07-21 | 59.67x |
| 2021-07-20 | 58.96x |
| 2021-07-19 | 58.47x |
| 2021-07-16 | 50.95x |
| 2021-07-15 | 47.60x |
| 2021-07-14 | 51.06x |
| 2021-07-13 | 48.50x |
| 2021-07-12 | 52.41x |
| 2021-07-09 | 51.29x |
| 2021-07-08 | 50.01x |
| 2021-07-07 | 47.94x |
| 2021-07-06 | 55.08x |
| 2021-07-02 | 52.38x |
| 2021-07-01 | 45.04x |
| 2021-06-30 | 45.61x |
| 2021-06-29 | 56.63x |
| 2021-06-28 | 61.52x |
| 2021-06-25 | 54.37x |
| 2021-06-24 | 52.90x |
| 2021-06-23 | 51.96x |
| 2021-06-22 | 53.02x |
| 2021-06-21 | 55.65x |
| 2021-06-18 | 52.79x |
| 2021-06-17 | 50.76x |
| 2021-06-16 | 53.13x |
| 2021-06-15 | 53.51x |
| 2021-06-14 | 54.37x |
| 2021-06-11 | 54.18x |
| 2021-06-10 | 59.15x |
| 2021-06-09 | 57.00x |
| 2021-06-08 | 53.24x |
| 2021-06-07 | 54.78x |
| 2021-06-04 | 45.80x |
| 2021-06-03 | 42.03x |
| 2021-06-02 | 42.19x |
| 2021-06-01 | 41.96x |
| 2021-05-28 | 41.62x |
| 2021-05-27 | 42.11x |
| 2021-05-26 | 40.34x |
| 2021-05-25 | 38.24x |
| 2021-05-24 | 42.60x |
| 2021-05-21 | 49.18x |
| 2021-05-20 | 52.72x |
| 2021-05-19 | 47.41x |
| 2021-05-18 | 52.94x |
| 2021-05-17 | 53.20x |
| 2021-05-14 | 50.99x |
